Related Experiment Videos
Differential response patterns to MAO inhibitors and tricyclics
The Journal of Clinical Psychiatry
|July 1, 1984
Summary
Monoamine oxidase inhibitors demonstrate superior effects for anxiety and panic disorders, even when atypical depression is present. These antidepressants offer distinct benefits compared to tricyclic antidepressants.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Atypical depression presents unique challenges in treatment.
- Understanding the comparative efficacy of different antidepressant classes is crucial.
Purpose of the Study:
- To review the concept of atypical depression.
- To compare the clinical effects of monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs).
Main Methods:
- Literature review of atypical depression.
- Comparative analysis of clinical data for MAOIs and TCAs.
Main Results:
- MAOIs are indicated for panic and generalized anxiety syndromes, with or without atypical depression.
- MAOIs and TCAs exhibit contrasting effects on adrenergic metabolism.
- MAOIs show superior antianxiety and antipanic effects.
Conclusions:
- The contrasting adrenergic metabolism effects may explain the superior antianxiety and antipanic efficacy of MAOIs.
- MAOIs represent a key therapeutic option for anxiety and panic disorders comorbid with atypical depression.